Q BioMed, Inc's (OTCQB: QBIO) Denis Corin presents to investors at the Proactive One2One Virtual Conference.
Q BioMed is a biotech acceleration and commercial stage company, focused on licensing and acquiring undervalued biomedical assets in the healthcare sector.
Add related topics to MyProactive
Create your account: sign up and get ahead on news and events
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Q BioMed Inc. named herein, including the promotion by the Company of Q BioMed Inc. in any Content on the Site, the Company receives from said...
FOR OUR FULL DISCLAIMER CLICK HERE